GreenLight Biosciences (GRNA)
0.30
0.00 (0.13%)
At close: Jul 21, 2023, 8:00 PM
0.13% (1D)
| Bid | n/a |
| Market Cap | 45.43M |
| Revenue (ttm) | 10.2M |
| Net Income (ttm) | -158.07M |
| EPS (ttm) | -1.12 |
| PE Ratio (ttm) | -0.2674107142857143 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 143,167 |
| Avg. Volume (20D) | 684,804 |
| Open | 0.30 |
| Previous Close | 0.30 |
| Day's Range | 0.30 - 0.30 |
| 52-Week Range | 0.18 - 5.90 |
| Beta | 1.44 |
About GRNA
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts....
Industry Biotechnology
Sector Healthcare
IPO Date Feb 3, 2022
Employees 280
Stock Exchange NASDAQ
Ticker Symbol GRNA